Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

TBC (indacaterol /mometasone furoate)

Indications: Asthma maintenance (adults, children 12 or older)

Call For Patient Input: March 31, 2020

Patient Input Closed: May 21, 2020

TBC (Indacaterol glycopyrronium mometasone furoate)

Indications: Asthma maintenance, adults

Call For Patient Input: March 31, 2020

Patient Input Closed: May 21, 2020

Entresto (sacubitril/valsartan)

Indications: Heart failure, NYHA Class II or III

Call For Patient Input: March 30, 2020

Patient Input Closed: May 20, 2020

TBC (fremanezumab)

Indications: migraine

Call For Patient Input: March 30, 2020

Patient Input Closed: May 20, 2020

Luxturna (voretigene neparvovec)

Indications: Vision loss, inherited retinal dystrophy

Call For Patient Input: March 25, 2020

Patient Input Closed: May 14, 2020

Soliris (eculizumab)

Indications: Myasthenia Gravis (gMG), adults

Call For Patient Input: March 4, 2020

Patient Input Closed: April 23, 2020

Forxiga (dapagliflozin)

Indications: Heart failure with reduced ejection fraction

Call For Patient Input: March 3, 2020

Patient Input Closed: April 22, 2020